Trial
NCT03296098
Study of the Safety and Efficacy of Ulipristal Acetate (UPA) Used Daily as a Contraceptive
Phase IIWITHDRAWNREGULATORYConfidence: HIGH
Sponsor
Premier Research
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Condition
Contraception
Intervention
Ulipristal acetate
Why stopped
withdrawn due to FDA feedback
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-20